Company intelligence / Profile preview

Metaplanet

Tallinn, Estonia

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Metaplanet invests in early-stage, evidence-based biotech and deep tech ventures that include pioneers in RNA medicines, in vivo screening, immunotherapies, AI in drug discovery, and more; several portfolio companies have advanced technologies but overall clinical results vary by company.

Therapeutic areas: ImmunologyMetabolic DisordersInfectious DiseasesOtherOncologyNeurology
Modalities: Small moleculeBiologicRNA therapymRNA-based drugsGene therapyCell therapyMonoclonal antibody
Industry: Investors

Partnerships

Portfolio collaborationsco-invests with leading VCsworks with biotech founders

Beyond the preview

Go deeper on Metaplanet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metaplanet.

Explore the full profile